Literature DB >> 8364489

Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.

M Okude1, A Yamanaka, Y Morimoto, S Akihama.   

Abstract

The final stage in a series of blood coagulating reactions is fibrinogen-fibrin conversion by thrombin. This reaction consists of fibrinopeptide A and fibrinopeptide B release, polymerization of fibrin monomer, and stabilized fibrin formation by factor XIII. The latter two reactions require calcium. In the present study there was no difference in the rate of thrombin-induced fibrinopeptide release between fibrinogen and asialofibrinogen where sialic acid in the terminal end of carbohydrate moiety of fibrinogen was removed by neuraminidase, but turbidity associated with asialofibrin clot formation was increased more rapidly. In asialo-derivatives, the dissolution time of the clots in high concentrated urea solution tended to be shortened and rigidity as a gel tended to be decreased. In measurement by thromboelastography there was no difference in the reaction time (r) between fibrinogen and asialofibrinogen, but the maximum amplitude (ma) was obviously decreased in asialofibrinogen. Furthermore, when the rate of cross-link formation between gamma chains by F-XIII was compared, the production of gamma-dimer in the same reaction time was found to be lower and formation of stabilized fibrin tended to be retarded in asialofibrinogen. Sialic acid in fibrinogen thus may clearly influence the polymerization of fibrin-monomer and the formation of cross-linked fibrin in a series of reactions for fibrinogen-fibrin conversion. This may be consistent with the theory that fibrinogen sialic acid residues are low affinity calcium-binding sites and influence fibrin assembly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364489     DOI: 10.1248/bpb.16.448

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin.

Authors:  Kimie Date; Mami Ohyama; Haruko Ogawa
Journal:  Glycoconj J       Date:  2015-06-07       Impact factor: 2.916

2.  Development of Transient Recombinant Expression and Affinity Chromatography Systems for Human Fibrinogen.

Authors:  Grega Popovic; Nicholas C Kirby; Taylor C Dement; Kristine M Peterson; Caroline E Daub; Heather A Belcher; Martin Guthold; Adam R Offenbacher; Nathan E Hudson
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 6.208

3.  Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.

Authors:  Judith J de Vries; Charlotte J M Snoek; Dingeman C Rijken; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-09       Impact factor: 8.311

4.  COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.

Authors:  Nina Moiseiwitsch; Nicole Zwennes; Fania Szlam; Roman Sniecinski; Ashley Brown
Journal:  J Thromb Haemost       Date:  2022-09-16       Impact factor: 16.036

5.  Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.

Authors:  Benjamin Planquette; Olivier Sanchez; James J Marsh; Peter G Chiles; Joseph Emmerich; Grégoire Le Gal; Guy Meyer; Tanya Wolfson; Anthony C Gamst; Roger E Moore; Gabriel B Gugiu; Timothy A Morris
Journal:  Eur Respir J       Date:  2018-11-15       Impact factor: 33.795

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.